Generation and characterization of induced pluripotent stem cell line (IBBISTi004-A) from an Angelman syndrome patient carrying a class II deletion of the maternal chromosome 15q11.2-q13


Angelman Syndrome is a rare neurodevelopmental disorder caused by several (epi)genetic alterations. The patients present strong neurological impairment due to the absence of a functional maternal UBE3A gene in neurons. Here, we generated and characterized a new induced pluripotent stem cell (iPSC) line from a female child with Angelman syndrome harbouring a class II deletion. iPSCs were reprogrammed from fibroblasts using Sendai viruses. The new iPSCs express pluripotency markers, are capable of trilineage in vitro differentiation and have the expected imprinting status of Angelman syndrome. These iPSCs are a valuable tool to elucidate the pathophysiological mechanisms associated with this disease. Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Authors Maranga C, Pereira C, Raposo AC, Vieira A, Duarte S, Bekman EP, Milagre I, da Rocha ST
Journal Stem cell research
Publication Date 2022 May;61:102757
PubMed 35339881
DOI 10.1016/j.scr.2022.102757

Research Projects

Cell Lines